| dc.contributor.author | Tutar L. | |
| dc.contributor.author | Özgür A. | |
| dc.contributor.author | Tutar Y. | |
| dc.date.accessioned | 2019-11-24T20:57:55Z | |
| dc.date.available | 2019-11-24T20:57:55Z | |
| dc.date.issued | 2018 | |
| dc.identifier.issn | 1064-3745 | |
| dc.identifier.uri | https://dx.doi.org/10.1007/978-1-4939-7435-1_3 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12513/2913 | |
| dc.description | PubMed ID: 29086367 | en_US |
| dc.description.abstract | Our understanding of cancer pathways has been changed by the determination of noncoding transcripts in the human genome in recent years. miRNAs and pseudogenes are key players of the noncoding transcripts from the genome, and alteration of their expression levels provides clues for significant biomarkers in pathogenesis of diseases. Especially, miRNAs and pseudogenes have both oncogenic and tumor-suppressive roles in each step of cancer tumorigenesis. In this current study, association between oncogenes and miRNAs-pseudogenes was reviewed and determined in human cancer by the CellMiner web-tool. © 2018, Springer Science+Business Media LLC. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Humana Press Inc. | en_US |
| dc.relation.isversionof | 10.1007/978-1-4939-7435-1_3 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Biomarker | en_US |
| dc.subject | Cancer | en_US |
| dc.subject | CellMiner | en_US |
| dc.subject | miRNA | en_US |
| dc.subject | Pseudogene | en_US |
| dc.title | Involvement of miRNAs and pseudogenes in cancer | en_US |
| dc.type | bookPart | en_US |
| dc.relation.journal | Methods in Molecular Biology | en_US |
| dc.contributor.department | Kırşehir Ahi Evran Üniversitesi, Fen-Edebiyat Fakültesi, Moleküler Biyoloji ve Genetik Bölümü | en_US |
| dc.identifier.volume | 1699 | en_US |
| dc.identifier.startpage | 45 | en_US |
| dc.identifier.endpage | 66 | en_US |
| dc.relation.publicationcategory | Kitap Bölümü - Uluslararası | en_US |
